-
-
CEO MacMillan wants you to meet ‘the new Hologic’
-
CRISPR Tx on active deal hunt but director cautions it’s ‘still early days’
Intuitive CEO lauds ‘fantastic’ robotic surgery growth in 2023 despite GLP-1 impact, manufacturing issues
J&J’s Biosense Webster claims pulsed field ablation approval in Japan
BioNTech, keeping its powder dry, pays WuXi $20M for 2 preclinical monoclonal antibodies
In The News
- Economic Storm Clouds Hovering Over Trump and Global Leaders August 25, 2019 By News Team
- UN: Possible to Eradicate Malaria, but Probably Not Soon August 24, 2019 By News Team
- Climate Change Turns Arctic Into Strategic, Economic Hotspot August 23, 2019 By News Team
Biotechnology Today
more-
Fortrea, Veeva and Advarra in pact to streamline clinical trials
Fortrea, the CRO that spun out of Labcorp last year, is linking up with trial…
CEO MacMillan wants you to meet ‘the new Hologic’
CRISPR Tx on active deal hunt but director cautions it’s ‘still early days’
Intuitive CEO lauds ‘fantastic’ robotic surgery growth in 2023 despite GLP-1 impact, manufacturing issues
FDA approves Medtronic’s rechargeable deep brain stimulator for Parkinson’s, epilepsy and more
Markets
more-
Weekly Market Review – April 13, 2024
Stock Markets The major indexes this week all headed southward on the back of a…
Bio Space
moreJ&J’s Biosense Webster claims pulsed field ablation approval in Japan
Johnson & Johnson’s Biosense Webster division has claimed the first…
BioNTech, keeping its powder dry, pays WuXi $20M for 2 preclinical monoclonal antibodies
BioNTech is continuing to add to its sprawling R&D portfolio…
Gene editors talk business development; Roivant CEO has money to spend
We’re off for another day of the J.P. Morgan Healthcare…
Global News
moreSpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Facebook video calls soar 1000% during Italy’s lockdown
Facebook has seen usage across its platforms surge in countries…
WeWork board’s special committee is demanding that SoftBank follow through with investment
Five months after SoftBank agreed to a massive bailout of…
- Fortrea, Veeva and Advarra in pact to streamline clinical trials
- CEO MacMillan wants you to meet ‘the new Hologic’
- CRISPR Tx on active deal hunt but director cautions it’s ‘still early days’
- Intuitive CEO lauds ‘fantastic’ robotic surgery growth in 2023 despite GLP-1 impact, manufacturing issues
- J&J’s Biosense Webster claims pulsed field ablation approval in Japan
- BioNTech, keeping its powder dry, pays WuXi $20M for 2 preclinical monoclonal antibodies
- Gene editors talk business development; Roivant CEO has money to spend
- Sanofi CEO does not rule out future Pompe-focused BD despite aggressive FTC
- FDA approves Medtronic’s rechargeable deep brain stimulator for Parkinson’s, epilepsy and more
- Labcorp inks collaboration with trial software firm Hawthorne Effect to speed up decentralized studies